Background Image
Table of Contents Table of Contents
Previous Page  9 / 61 Next Page
Information
Show Menu
Previous Page 9 / 61 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 4, July/August 2021

AFRICA

181

number of studies and clinical practice that NLR serves as

an evaluation index for diagnosis and prognosis of patients with

cardiac insufficiency.

11

Determining NLR in plasma in patients

with CHF and AF has been a subject of study in recent years. It is

currently believed that NLR is an ideal marker of myocardial injury,

and the level has a significant positive correlation with the degree of

myocardial injury.

12

NLR has predictive value for the prognosis of a variety of

cardiovascular diseases.

13

Patients with coronary heart disease have

a higher NLR in plasma.

14

Furthermore, NLR in plasma is higher

in patients with acute myocardial infarction than that in patients

with unstable angina, while it is also higher in the latter than

that in patients with stable angina. After correcting for a variety

of traditional cardiovascular risk factors, NLR can be used as a

predictor for major adverse events of AF.

15

In our study, the results

of logistic regression analysis showed that NLR was an independent

predictive factor for MACE in patients with CHF and AF.

In our study, the patients were divided into four groups based on

the quartile of NLR. It was found that the difference in incidence

of MACE was statistically significant between the four groups (

p

< 0.05), manifesting as increased incidence of acute myocardial

infarction, severe arrhythmia and cardiac death with increasing

NLR. AF raises both resting heart rate and response heart

rate, further reducing cardiac output and elevating cardiac filling

pressure, which is the internal cause of aggravation of HF by AF

and an important factor causing acute myocardial infarction.

16

AF is

a common type of arrhythmia, and CHF can further enhance atrial

depolarisation and repolarisation dispersion and cause re-entry

more easily, thereby leading to severe arrhythmia.

17

In this study, according to the analysis results of Kaplan–Meier

survival curves, the duration of MACE in group D was significantly

shorter than that in groups A and B. Yýlmaz

et al

. demonstrated

that NLR > 3.08 was an independent predictor of new-onset

myocardial infarction and in-hospital death in patients with HF.

18

In our study, the ROC curves showed that the optimal cut-off value

and area under the curve of NLR for MACE in patients with CHF

and AF were 3.12 and 0.879, respectively, confirming their high

diagnostic value.

Conclusion

NLR was an independent predictive factor for MACE in these

patients with CHF and AF, and it had high diagnostic value, which

is of importance for adopting the appropriate therapeutic regimen

and improving prognosis as early as possible.

This study was financially supported by Xintai Research and Development

Project (No 2020ZC272).

References

1.

Fontana J, Zima M, Vetvicka V. Biological markers of oxidative stress

in cardiovascular diseases: after so many studies, what do we know?

Immunol Invest

2018;

47

(8): 823–843.

2.

Ayesta A, Martinez-Selles H, de Luna AB,

et al.

Prediction of sudden

death in elderly patients with heart failure.

J Geriatr Cardiol

2018;

15

(2):

185–192.

3.

Yalcinkaya E, Yuksel UC, Celik M,

et al.

Relationship between neutro-

phil-to-lymphocyte ratio and electrocardiographic ischemia grade in

STEMI.

Arq Bras Cardiol

2015;

104

(2): 112–119.

4.

Awad F, Assrawi E, Jumeau C,

et al.

Impact of human monocyte and

macrophage polarization on NLR expression and NLRP3 inflamma-

some activation.

Plos One

2017;

12

(4): e0175336.

5.

Shang X, Xiao S, Dong N,

et al.

Assessing right ventricular function

in pulmonary hypertension patients and the correlation with the New

York Heart Association (NYHA) classification.

Oncotarget

2017;

8

(52):

90421.

6.

Zhu Q, Xiao W, Bai Y,

et al.

The prognostic value of the plasma

N-terminal pro-brain natriuretic peptide level on all-cause death and

major cardiovascular events in a community-based population.

Clin

Interv Aging

2016;

11

: 245–253.

7.

Richards AM, Troughton RW. Use of natriuretic peptides to guide and

monitor heart failure therapy.

Clin Chem

2012;

58

(1): 62–71.

8.

Guan P, Liang Y, Wang N. Fasudil alleviates pressure overload-induced

heart failure by activating Nrf2-mediated antioxidant responses.

J Cell

Biochem

2018;

119

(8): 6452–6460.

9.

Tahto E, Jadric R, Pojskic L,

et al.

Neutrophil-to-lymphocyte ratio and

its relation with markers of inflammation and myocardial necrosis in

patients with acute coronary syndrome.

Med Arch

2017;

71

(5): 312–315.

10. Yan W, Li JZ, He KL. The relationship between neutrophil-to-lympho-

cyte ratio and major cardiovascular events in elderly patients with

chronic heart failure.

J Geriatr Cardiol

2017;

14

(12): 780.

11. Budzianowski J, Pieszko K, Burchardt P,

et al.

The role of hematologi-

cal indices in patients with acute coronary syndrome.

Dis Markers

2017;

2017

: 3041565.

12. Durmu

ş

G, Belen E, Can MM. Increased neutrophil to lymphocyte ratio

predicts myocardial injury in patients undergoing non-cardiac surgery.

Heart Lung

2018;

47

(3): 243–247.

13. Zhang S, Diao J, Qi CM,

et al.

Predictive value of neutrophil to lympho-

cyte ratio in patients with acute ST segment elevation myocardial infarc-

tion after percutaneous coronary intervention: a meta-analysis.

BMC

Cardiovasc Disord

2018;

18

(1): 75.

14. Wang X, Fan X, Ji S,

et al.

Prognostic value of neutrophil to lymphocyte

ratio in heart failure patients.

Clin Chim Acta

2018;

485

: 44–49.

15. Dong G, Huang A, Liu L. Platelet-to-lymphocyte ratio and prognosis in

STEMI: a meta-analysis.

Eur J Clin Invest

2020; e13386.

16. Verdoia M, Barbieri L, Di Giovine G,

et al.

Neutrophil to lymphocyte

ratio and the extent of coronary artery disease: results from a large

cohort study.

Angiology

2016;

67

(1): 75–82.

17. Wändell P, Carlsson AC, Holzmann MJ,

et al.

The association between

relevant co-morbidities and prevalent as well as incident heart failure in

patients with atrial fibrillation. J

Cardiol

2018;

72

(1): 26–32.

18. Yýlmaz S, Canpolat U, Baþer K,

et al.

Neutrophil-to-lymphocyte ratio

predicts functionally significant coronary artery stenosis in patients

with stable coronary artery disease.

Arch Turk Soc Cardiol

2018;

46

(2):

129–135.